Skip to content

The Anticariogenic Effect of Miswak (Silvadora Persica) and Grape Seed Extract

The Anticariogenic Effect of Miswak (Silvadora Persica) and Grape Seed Extract

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04136639
Enrollment
30
Registered
2019-10-23
Start date
2019-06-01
Completion date
2019-10-01
Last updated
2019-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries

Brief summary

Prevention of dental caries has taken a great importance in the last decade. The use of herbal and natural products became mandatory to avoid the side effects of commercially available medications. Aim of the study; the aim was to investigate the anti-cariogenic effect of miswak and grape seed extract (GSE).

Detailed description

Patients used Miswak sticks, grape seed extract mouth wash and fluoride mouthwash twice daily for three month. Saliva samples were collected at base line and after one month and three month. Assessment of bacterial count and saliva buffering capacity were performed at base line and after one and three month.

Interventions

OTHERMiswak

sticks

OTHERfluoride

mouthwash

Sponsors

Al-Azhar University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with high caries risk * Males or females * Medically free patients * Patients approving to participate in the study

Exclusion criteria

* Patients who were on antibiotic therapy or corticosteroid therapy for 30 days before the examination * Patients had history of professional cleaning in the last 15 days * Patients with exposed pulp * Evidence of parafunctional habits * Patients with developmental dental anomalies * Patients undergoing or will start orthodontic treatment * Patients with removable prosthesis * Periapical Abscess or Fistula

Design outcomes

Primary

MeasureTime frameDescription
quantitative measure of the change in salivary streptococcus mutans Count from baseline to one month and three months.Baseline, one month, three months.the patients used the treatments twice daily for three months. unstimulated saliva samples were collected from the patients at baseline,after one month and after three months. Every time samples were incubated with Mitiis Salivaris with Bacitricin and 20% sucrose for streptococcus mutans count.

Secondary

MeasureTime frameDescription
quantitative measure of the change in saliva buffering capacity from baseline to one month and three months.baseline, one month , three monthsthe patients used the treatments twice daily for three months. unstimulated saliva samples were collected from the patients at baseline, after one month and after three months. each time, saliva buffering capacity was measured using Hand Held pH meter and 0.1 mol/l hydrochloric acid that was titrated to the tested saliva.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026